Skandinaviska Enskilda Banken (SEB)
ACOR

Skandinaviska Enskilda Banken (SEB)’s Acorda Therapeutics ACOR Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,503
Closed -$857K – 947
2019
Q4 		$857K Buy
+3,503
New +$884K 0.01% 743
2017
Q3 		– Sell
-180
Closed -$426K – 750
2017
Q2 		$426K Sell
180
-936
-84% -$1.85M ﹤0.01% 669
2017
Q1 		$2.81M Sell
1,116
-533
-32% -$1.53M 0.03% 386
2016
Q4 		$3.72M Hold
1,649
– – 0.04% 276
2016
Q3 		$4.13M Buy
1,649
+846
+105% +$2.52M 0.04% 294
2016
Q2 		$2.46M Buy
+803
New +$2.61M 0.03% 402

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ACOR Position: Q1 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Acorda Therapeutics (ACOR) in Q1 2020, closing a stake of 3,503 shares — an estimated $857K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ACOR in Q2 2016 and held it in 6 quarters. The position peaked at $4.13M in Q3 2016. 106 funds tracked by Wall St. Rank hold ACOR as of Q1 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Acorda Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 3,503 Acorda Therapeutics shares in Q1 2020, an estimated $857K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Acorda Therapeutics in Q2 2016 and held it in 6 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Acorda Therapeutics position peaked at $4.13M in Q3 2016.
  • 106 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2020, filed 13 May 2020.